Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
- 作者: Gracheva S1, Biragova M1, Glazunova A1, Klefortova I1, Shamkhalova M1, Dzhavelidze M1, Soldatova T1, Il'in A1, Shestakova M1,2, Tugeeva É3, Buziashvili I.3
-
隶属关系:
- ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
- ГБОУ ВПО "Первый МГМУ им. И.М. Сеченова" Минздрава России
- Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева РАМН, Москва
- 期: 卷 86, 编号 10 (2014)
- 页面: 20-26
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31559
- ID: 31559
如何引用文章
全文:
详细
作者简介
S Gracheva
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
Email: sgracheva@mail.ru
M Biragova
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
A Glazunova
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
I Klefortova
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
M Shamkhalova
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
M Dzhavelidze
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
T Soldatova
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
A Il'in
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва
M Shestakova
ФГБУ "Эндокринологический научный центр" Минздрава России, Москва; ГБОУ ВПО "Первый МГМУ им. И.М. Сеченова" Минздрава России
É Tugeeva
Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева РАМН, Москва
Iu Buziashvili
Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева РАМН, Москва
参考
- Morikami Y., Natsuaki M., Morimoto T., Ono K. еt аl. CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: anobservation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis 2013; 228 (2): 426-431.
- Дедов И.И, Шестакова М.В. Сахарный диабет: острые и хронические осложнения. М: Медицинское информационное агентство 2011; 338.
- Pambianco G., Costacou T., Ellis D., Becker D.J. еt аl. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006; 55 (5): 1463-1469.
- Elkeles R.S. Coronary artery calcium and cardiovascular risk in diabetes. Atherosclerosis 2010; 210 (2): 331-336.
- Soedamah-Muthu S.S., Chaturvedi N., Toeller M. еt аl. EURODIAB Prospective Complications Study Group. Risk factors for coronary heart disease in type 1 diabetic patients in Europe The EURODIAB Prospective Complications Study. Diabetes Care 2004; 27 (2): 530-537.
- Menon V., Wang X., Greene T. еt аl. Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. Kidney Int 2005; 67 (4): 1539-1546.
- Miura T., Soga Y., Doijiri T. еt аl. Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention. Circulation 2013; 77 (1): 89-95.
- Sarnak M.J., Levey A.S., Schoolwerth A.C. еt аl. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.Kidney disease as a risk factor for development of cardiovascular disease a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108 (17): 2154-2169.
- Tonelli M., Muntner P., Lloyd A. еt аl. Alberta Kidney Disease Network. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. The Lancet 2012; 380 (9844): 807-814.
- Patel A., MacMahon S., Chalmers J. еt аl. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358 (24): 2560-2572.
- Grassi G. The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. Expert Opin Pharmacother 2011; 12 (15): 2421-2424.
- Baigent C., Landray M.J., Reith C. еt аl. SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 2011; 377 (9784): 2181-2192.
- Miller L.M., Sood M.M., Sood A.R. еt аl. Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Intern Urol Nephrol 2010; 42 (4): 1007-1014.
- Rangel E.B., de Sa J.R., Melaragno C.S. еt аl. Kidney transplant in diabetic patients: modalities, indications and RESULTS. Diabetol Metabol Syndrome 2009; 1: 2.
- Al Thani H., El-Menyar A., Alhabib K.F. еt аl. Polyvascular disease in patients presenting with acute coronary syndrome: its predictors and outcomes. Scientific World J 2011; 2012 (2012): 7.
- Feinbloom D., Bauer K. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 2005; 25 (10): 2043-2053.
- Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294 (14): 1799-1809.
- Green D., Foiles N., Chan C. еt аl. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis 2009; 202 (2): 623-631.
- Deepak L. Bhatt, Kim A. Eagle, E. Magnus Ohman еt аl. REACH Registry Investigators. Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis. JAMA 2010; 304 (12): 1350-1357.
- Bhatt D.L., Peterson E.D., Harrington R.A. еt аl. CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 2009; 30 (10): 1195-202.